Harvard Bioscience (HBIO) Research & Development (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Research & Development data on file, last reported at $5.3 million in Q1 2026.

• On a quarterly basis, Research & Development rose 7.32% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $24.6 million, a 15.51% increase from a year earlier, with the FY2025 full-year figure at $19.2 million, down 13.49% from the prior year.
• Research & Development for Q1 2026 stood at $5.3 million, down from $12.6 million in the prior quarter.
• Over the last five years, Research & Development for HBIO reached as high as $15.4 million in Q4 2023 and fell as low as $2.1 million in Q3 2025.
• Historically, Research & Development has averaged $5.8 million across 5 years, with a median of $5.4 million in 2024.
• Across the five-year window, Research & Development jumped 168.88% in 2022 and slumped 65.07% in 2024, its largest moves.
• Year by year, Research & Development stood at $5.9 million in 2022, then surged by 159.68% to $15.4 million in 2023, then slumped by 65.07% to $5.4 million in 2024, then soared by 133.07% to $12.6 million in 2025, then slumped by 57.57% to $5.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $5.3 million in Q1 2026, $12.6 million in Q4 2025, and $2.1 million in Q3 2025.